Skip to main content
. 2024 Jun 3;14:12660. doi: 10.1038/s41598-024-63578-8

Table 2.

Intraoperative variables in patients received remimazolam-flumazenil or propofol during radiofrequency catheter ablation of atrial fibrillation.

Remimazolam-flumazenil group
(n = 26)
Propofol group
(n = 27)
P
Time to loss of consciousness (s) 101 (84–114) 121 (70–161) 0.328
Time to eye opening (s) 174 (157–216) 353 (230–483)  < 0.001
Time to extubation (s) 211 (177–268) 382 (308–572)  < 0.001
Duration of procedure (min) 142 (39) 135 (42) 0.532
Total infused remifentanil (μg) 656 (271) 623 (170) 0.604
Total administered propofol (mg) 1195 (268) NA
Total administered remimazolam (mg) 354 (108) NA
Total administered flumazenil (mg) 0.3 (0.3–0.4) NA
Total infused crystalloid (mL) 600 (475–763) 600 (350–700) 0.447
Urine output (mL) 400 (233–915) 650 (300–855) 0.552
Incidence of intraprocedural hypotension* 3 (12%) 1 (4%) 0.341
Use of norepinephrine during procedure 22 (85%) 24 (89%) 0.704
Maximum dosage of norepinephrine administration (μg/kg/min) 0.04 (0.02–0.06) 0.04 (0.02–0.07) 0.641
Duration of norepinephrine infusion (min) 94 (66) 107 (64) 0.458

Data are presented as median (interquartile range), mean (SD), or number (%). NA, not applicable.

*Intraoperative hypotension was defined when three consecutive systolic blood pressure < 80 mmHg at 2.5 min-interval was detected.